Abstract:Cancer is a class of diseases with high mortality rate, characterized by unregulated cell growth. Early diagnosis of cancer is currently the most effective method to prevent cancer development and improve the survival rate of patients. Traditional diagnostic methods such as biopsy usually provoke discomfort and unpleasant experience. Recently, microRNAs (miRNAs) were widely reported to be potential biomarkers to detect cancers without invasiveness. MicroRNA-21 (miRNA-21, miR-21) is one of the most prevalent miRNAs. This meta-analysis aims to make a comprehensive analysis of the potential role of circulating miR-21 as a biomarker in human carcinoma diagnosis. A total of 36 articles involving 2920 cancer patients and 1986 healthy controls with regard to the diagnostic value of the circulating miR-21 for cancer detection were selected from online bibliographic databases. For pooled analysis, the sensitivity, specificity, and other basic characteristics were extracted from the 36 included articles. Then, bivariate random-effects model was selected to gain pooled results. Furthermore, to explore the sources of heterogeneity, we conducted stratified and meta-regression analyses based on different race/sample groups. The pooled characteristics of all included articles were as follows: sensitivity, 0.78 (95% confidence intervals (CI), 0.73-0.82); specificity, 0.82 (95% CI, 0.79-0.86); positive likelihood ratio (PLR), 4.4 (95% CI, 3.6-5.4); negative likelihood ratio (NLR), 0.26 (95% CI, 0.21-0.33); diagnostic odds ratio (DOR), 17 (95% CI, 12-24); and area under the curve (AUC), 0.87 (95% CI, 0.84-0.90). The subgroup analyses results based on different ethnic populations revealed that the diagnostic accuracy of miR-21 tends to be higher in Asian populations than in Caucasian populations. Furthermore, another subgroup analysis performed on sample types suggested that the serum-based specimen used in cancer diagnosis appeared to be more accurate than the plasma-based specimen. Our meta-analysis shows that the circulating miR-21 may be a potential biomarker as diagnostic tool for early-stage cancer diagnosis.

Circulating Microrna-21 (Mir-21) and Phosphatase and Tensin Homolog (pten) Are Promising Novel Biomarkers for Detection of Oral Squamous Cell Carcinoma

Evaluation of Plasma Mir-21 and Mir-152 As Diagnostic Biomarkers for Common Types of Human Cancers

Elevated Expression of Exosomal Microrna-21 As a Potential Biomarker for the Early Diagnosis of Pancreatic Cancer Using a Tethered Cationic Lipoplex Nanoparticle Biochip.

Mir-31-5p is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer

Circulating Mirna-21-5p As a Diagnostic Biomarker for Pancreatic Cancer: Evidence from Comprehensive Mirna Expression Profiling Analysis and Clinical Validation

Altered Expression of Mir-21 and PTEN in Human Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.

Clinical Diagnostic Implications Of Body Fluid Mirna In Oral Squamous Cell Carcinoma

Microrna-21 and Microrna-375 from Oral Cytology As Biomarkers for Oral Tongue Cancer Detection.

Mir-21 and Mir-375 Micrornas As Candidate Diagnostic Biomarkers in Squamous Cell Carcinoma of the Larynx: Association with Patient Survival.

Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma.

Circulating Plasma Mirnas As Potential Biomarkers of Non-Small Cell Lung Cancer Obtained by High-Throughput Real-Time PCR Profiling

MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer

Expression Analysis of Circulating microRNAs in Saliva and Plasma for the Identification of Clinically Relevant Biomarkers for Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders

Dysregulation of miR-21-5p, miR-93-5p, miR-200c-3p and miR-205-5p in Oral Squamous Cell Carcinoma: A Potential Biomarkers Panel?

Circulating Microrna-21 As a Biomarker for the Detection of Various Carcinomas: an Updated Meta-Analysis Based on 36 Studies

Diagnostic Value Of Circulating Mir-155, Mir-21, And Mir-10b As Promising Biomarkers In Human Breast Cancer

Circulatory miRNA-155, miRNA-21 target PTEN expression and activity as a factor in breast cancer development

Circulating Exosomal Micrornas As Novel Potential Detection Biomarkers in Pancreatic Cancer

MiR-21 and mRNA PTEN Expression Levels and Biomarker Potential in Breast Cancer

Next-generation Sequencing for Microrna Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.

Deregulation of hsa_circ_0001971/miR-186 and hsa_circ_0001874/miR-296 signaling pathways promotes the proliferation of oral squamous carcinoma cells by synergistically activating SHP2/PLK1 signals